Sarepta Therapeutics, Inc. (SRPT)
18.13
-0.66
(-3.51%)
USD |
NASDAQ |
Aug 24, 16:00
18.13
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Total Return Level : 18.13 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 18.13 |
| August 21, 2026 | 18.79 |
| August 20, 2026 | 19.22 |
| August 19, 2026 | 19.73 |
| August 18, 2026 | 18.02 |
| August 17, 2026 | 18.18 |
| August 14, 2026 | 18.10 |
| August 13, 2026 | 18.42 |
| August 12, 2026 | 18.38 |
| August 11, 2026 | 18.22 |
| August 10, 2026 | 17.18 |
| August 07, 2026 | 16.78 |
| August 06, 2026 | 16.78 |
| August 05, 2026 | 15.93 |
| August 04, 2026 | 16.39 |
| August 03, 2026 | 15.88 |
| July 31, 2026 | 14.86 |
| July 30, 2026 | 15.56 |
| July 29, 2026 | 15.54 |
| July 28, 2026 | 15.43 |
| July 27, 2026 | 15.89 |
| July 24, 2026 | 15.68 |
| July 23, 2026 | 15.88 |
| July 22, 2026 | 15.82 |
| July 21, 2026 | 16.21 |
| Date | Value |
|---|---|
| July 20, 2026 | 16.83 |
| July 17, 2026 | 17.22 |
| July 16, 2026 | 17.23 |
| July 15, 2026 | 17.61 |
| July 14, 2026 | 17.96 |
| July 13, 2026 | 18.82 |
| July 10, 2026 | 18.95 |
| July 09, 2026 | 20.52 |
| July 08, 2026 | 20.21 |
| July 07, 2026 | 19.79 |
| July 06, 2026 | 19.18 |
| July 02, 2026 | 19.28 |
| July 01, 2026 | 18.20 |
| June 30, 2026 | 17.97 |
| June 29, 2026 | 17.02 |
| June 26, 2026 | 16.85 |
| June 25, 2026 | 16.02 |
| June 24, 2026 | 16.70 |
| June 23, 2026 | 17.26 |
| June 22, 2026 | 17.65 |
| June 18, 2026 | 17.53 |
| June 17, 2026 | 16.96 |
| June 16, 2026 | 15.78 |
| June 15, 2026 | 15.77 |
| June 12, 2026 | 15.31 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Moderna, Inc. | 138.89 |
| ImmunityBio, Inc. | 7.58 |
| X4 Pharmaceuticals, Inc. | 4.05 |
| MapLight Therapeutics, Inc. | 11.36 |